Literature DB >> 18316388

Modulation of the bovine trophoblastic innate immune response by Brucella abortus.

Alcina V Carvalho Neta1, Ana P R Stynen, Tatiane A Paixão, Karina L Miranda, Fabiana L Silva, Christelle M Roux, Renée M Tsolis, Robin E Everts, Harris A Lewin, L Garry Adams, Alex F Carvalho, Andrey P Lage, Renato L Santos.   

Abstract

Brucellosis is still a widespread zoonotic disease. Very little is known about the interaction between Brucella abortus and trophoblastic cells, which is essential for better understanding the pathogenesis of the Brucella-induced placentitis and abortion, a key event for transmission of the disease. The goal of this study was to evaluate the profile of gene expression by bovine trophoblastic cells during infection with B. abortus. Explants of chorioallantoic membranes were inoculated with B. abortus strain 2308. Microarray analysis was performed at 4 h after infection, and expression of cytokines and chemokines by trophoblastic cells was assessed by real-time reverse transcription-PCR at 6 and 12 h after inoculation. In addition, cytokine and chemokine expression in placentomes from experimentally infected cows was evaluated. Expression of proinflammatory genes by trophoblastic cells was suppressed at 4 h after inoculation, whereas a significant upregulation of CXC chemokines, namely, CXCL6 (GCP-2) and CXCL8 (interleukin 8), was observed at 12 but not at 6 h after inoculation. Placentomes of experimentally infected cows had a similar profile of chemokine expression, with upregulation of CXCL6 and CXCL8. Our data indicate that B. abortus modulates the innate immune response by trophoblastic cells, suppressing the expression of proinflammatory mediators during the early stages of infection that is followed by a delayed and mild expression of proinflammatory chemokines, which is similar to the profile of chemokine expression in the placentomes of experimentally infected cows. This trophoblastic response is likely to contribute to the pathogenesis of B. abortus-induced placentitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316388      PMCID: PMC2346690          DOI: 10.1128/IAI.01554-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Sugar metabolism by Brucellae.

Authors:  Richard C Essenberg; Rekha Seshadri; Karen Nelson; Ian Paulsen
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

3.  Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Authors:  V Jubier-Maurin; R A Boigegrain; A Cloeckaert; A Gross; M T Alvarez-Martinez; A Terraza; J Liautard; S Köhler; B Rouot; J Dornand; J P Liautard
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Prenatal development of domestic and laboratory mammals: growth curves, external features and selected references.

Authors:  H E Evans; W O Sack
Journal:  Zentralbl Veterinarmed C       Date:  1973-03

5.  Morphologic and molecular characterization of Salmonella typhimurium infection in neonatal calves.

Authors:  R L Santos; S Zhang; R M Tsolis; A J Bäumler; L G Adams
Journal:  Vet Pathol       Date:  2002-03       Impact factor: 2.221

6.  Urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) expression and activity during early embryo development in the cow.

Authors:  E J Whiteside; M Kan; M M Jackson; J G Thompson; C McNaughton; A C Herington; M B Harvey
Journal:  Anat Embryol (Berl)       Date:  2001-12

7.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus.

Authors:  Guillermo H Giambartolomei; Astrid Zwerdling; Juliana Cassataro; Laura Bruno; Carlos A Fossati; Mario T Philipp
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

9.  Cellular and humoral responses of Brucella abortus-infected bovine fetuses.

Authors:  F M Enright; J V Walker; G Jeffers; B L Deyoe
Journal:  Am J Vet Res       Date:  1984-03       Impact factor: 1.156

10.  Nutrition-induced ketosis alters metabolic and signaling gene networks in liver of periparturient dairy cows.

Authors:  Juan J Loor; Robin E Everts; Massimo Bionaz; Heather M Dann; Dawn E Morin; Rosane Oliveira; Sandra L Rodriguez-Zas; James K Drackley; Harris A Lewin
Journal:  Physiol Genomics       Date:  2007-10-09       Impact factor: 3.107

View more
  27 in total

Review 1.  Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

Authors:  Paul de Figueiredo; Thomas A Ficht; Allison Rice-Ficht; Carlos A Rossetti; L Garry Adams
Journal:  Am J Pathol       Date:  2015-04-17       Impact factor: 4.307

2.  Human trophoblast responses to Porphyromonas gingivalis infection.

Authors:  S D Riewe; J J Mans; T Hirano; J Katz; K T Shiverick; T A Brown; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

3.  Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain.

Authors:  Fang Chen; Xicheng Ding; Ying Ding; Zuoshuang Xiang; Xinna Li; Debashis Ghosh; Gerhardt G Schurig; Nammalwar Sriranganathan; Stephen M Boyle; Yongqun He
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

4.  Erythritol triggers expression of virulence traits in Brucella melitensis.

Authors:  Erik Petersen; Gireesh Rajashekara; Neelima Sanakkayala; Linda Eskra; Jerome Harms; Gary Splitter
Journal:  Microbes Infect       Date:  2013-02-16       Impact factor: 2.700

5.  Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses.

Authors:  Jill Covert; Angela J Mathison; Linda Eskra; Menachem Banai; Gary Splitter
Journal:  Exp Biol Med (Maywood)       Date:  2009-12

6.  Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen.

Authors:  Tatiane A Paixão; Christelle M Roux; Andreas B den Hartigh; Sumathi Sankaran-Walters; Satya Dandekar; Renato L Santos; Renée M Tsolis
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

Review 7.  The Role of Neutrophils in Brucellosis.

Authors:  Edgardo Moreno; Elías Barquero-Calvo
Journal:  Microbiol Mol Biol Rev       Date:  2020-10-14       Impact factor: 11.056

8.  Effects of vaccination against brucellosis and clostridia on the intake, performance, feeding behavior, blood parameters, and immune responses of dairy heifers calves.

Authors:  Hilton C Diniz Neto; Mayara C Lombardi; Mariana M Campos; Andrey P Lage; Rodrigo O S Silva; Elaine Maria Seles Dorneles; Camila Flávia A Lage; Wanessa A Carvalho; Fernanda S Machado; Luiz Gustavo R Pereira; Thierry R Tomich; Carolina P Ramos; Ronnie A Assis; Francisco Carlos F Lobato; Jordana A Santana; Ethiene Luiza S Santos; Rafaella S Andrade; Sandra G Coelho
Journal:  J Anim Sci       Date:  2021-05-01       Impact factor: 3.159

Review 9.  When the Going Gets Rough: The Significance of Brucella Lipopolysaccharide Phenotype in Host-Pathogen Interactions.

Authors:  Lauren W Stranahan; Angela M Arenas-Gamboa
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

Review 10.  Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.

Authors:  Yongqun He
Journal:  Front Cell Infect Microbiol       Date:  2012-02-01       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.